UBS AM’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-38,917
| Closed | -$188K | – | 2579 |
|
|
2020
Q1 | $188K | Sell |
38,917
-293
| -0.7% | -$1.42K | ﹤0.01% | 2293 |
|
|
2019
Q4 | $417K | Buy |
39,210
+7,745
| +25% | +$82.3K | ﹤0.01% | 2296 |
|
|
2019
Q3 | $328K | Buy |
31,465
+13,678
| +77% | +$142K | ﹤0.01% | 2431 |
|
|
2019
Q2 | $272K | Hold |
17,787
| – | – | ﹤0.01% | 2439 |
|
|
2019
Q1 | $229K | Buy |
17,787
+17,600
| +9,412% | +$226K | ﹤0.01% | 2412 |
|
|
2018
Q4 | $1.78K | Hold |
187
| – | – | ﹤0.01% | 2734 |
|
|
2018
Q3 | $3.1K | Hold |
187
| – | – | ﹤0.01% | 2716 |
|
|
2018
Q2 | $3K | Buy |
+187
| New | +$3K | ﹤0.01% | 2735 |
|